Bank of New York Mellon’s Pfizer PFE Stock Holding History

Bank of New York Mellon’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39B	Buy	57,879,546 +3,999,646	+7%	+$105M	0.23%	70
2026 Q1	$1.51B	Buy	53,879,900 +5,364,929	+11%	+$143M	0.28%	62
2025 Q4	$1.21B	Buy	48,514,971 +13,581,757	+39%	+$342M	0.21%	86
2025 Q3	$890M	Sell	34,933,214 -1,034,611	-3%	-$25.5M	0.16%	120
2025 Q2	$872M	Sell	35,967,825 -2,773,316	-7%	-$64.7M	0.16%	120
2025 Q1	$982M	Sell	38,741,141 -1,177,185	-3%	-$30.8M	0.19%	99
2024 Q4	$1.06B	Sell	39,918,326 -757,792	-2%	-$20.6M	0.2%	99
2024 Q3	$1.18B	Sell	40,676,118 -1,233,754	-3%	-$36M	0.22%	92
2024 Q2	$1.17B	Sell	41,909,872 -482,873	-1%	-$13.3M	0.22%	86
2024 Q1	$1.18B	Sell	42,392,745 -1,695,841	-4%	-$47.1M	0.23%	89
2023 Q4	$1.27B	Sell	44,088,586 -5,260,110	-11%	-$159M	0.26%	75
2023 Q3	$1.64B	Sell	49,348,696 -1,386,869	-3%	-$49M	0.36%	46
2023 Q2	$1.86B	Sell	50,735,565 -1,130,651	-2%	-$44M	0.39%	43
2023 Q1	$2.12B	Sell	51,866,216 -1,140,679	-2%	-$49.3M	0.46%	35
2022 Q4	$2.72B	Sell	53,006,895 -3,652,284	-6%	-$175M	0.62%	22
2022 Q3	$2.48B	Buy	56,659,179 +317,858	+0.6%	+$15.4M	0.6%	25
2022 Q2	$2.95B	Buy	56,341,321 +1,708,092	+3%	+$87M	0.68%	20
2022 Q1	$2.83B	Sell	54,633,229 -41,223	-0.1%	-$2.14M	0.55%	27
2021 Q4	$3.23B	Sell	54,674,452 -4,194,979	-7%	-$208M	0.58%	24
2021 Q3	$2.53B	Buy	58,869,431 +21,540	+0%	+$954K	0.49%	31
2021 Q2	$2.3B	Sell	58,847,891 -3,093,826	-5%	-$120M	0.45%	39
2021 Q1	$2.24B	Sell	61,941,717 -2,815,122	-4%	-$100M	0.46%	39
2020 Q4	$2.38B	Buy	64,756,839 +3,844,763	+6%	+$141M	0.52%	30
2020 Q3	$2.12B	Buy	60,912,076 +716,172	+1%	+$25.1M	0.52%	33
2020 Q2	$1.87B	Buy	60,195,904 +1,079,575	+2%	+$36.7M	0.5%	32
2020 Q1	$1.83B	Sell	59,116,329 -3,873,926	-6%	-$132M	0.61%	25
2019 Q4	$2.34B	Buy	62,990,255 +2,934,327	+5%	+$105M	0.6%	27
2019 Q3	$2.05B	Sell	60,055,928 -2,126,585	-3%	-$77.3M	0.56%	27
2019 Q2	$2.56B	Sell	62,182,513 -1,765,808	-3%	-$70.1M	0.7%	21
2019 Q1	$2.58B	Sell	63,948,321 -5,081,040	-7%	-$203M	0.72%	18
2018 Q4	$2.86B	Sell	69,029,361 -4,994,797	-7%	-$207M	0.9%	13
2018 Q3	$3.1B	Buy	74,024,158 +2,632,614	+4%	+$101M	0.8%	13
2018 Q2	$2.46B	Sell	71,391,544 -2,057,833	-3%	-$70.3M	0.67%	19
2018 Q1	$2.47B	Sell	73,449,377 -1,109,408	-1%	-$38.1M	0.68%	15
2017 Q4	$2.56B	Buy	74,558,785 +7,941,845	+12%	+$271M	0.67%	19
2017 Q3	$2.26B	Sell	66,616,940 -1,290,578	-2%	-$41.5M	0.62%	22
2017 Q2	$2.16B	Sell	67,907,518 -6,123,942	-8%	-$193M	0.61%	25
2017 Q1	$2.4B	Sell	74,031,460 -2,081,163	-3%	-$65.6M	0.67%	21
2016 Q4	$2.35B	Sell	76,112,623 -6,849,771	-8%	-$209M	0.68%	21
2016 Q3	$2.67B	Sell	82,962,394 -5,178,585	-6%	-$173M	0.79%	16
2016 Q2	$2.94B	Sell	88,140,979 -2,844,813	-3%	-$90.8M	0.9%	11
2016 Q1	$2.56B	Sell	90,985,792 -2,482,994	-3%	-$70.9M	0.77%	16
2015 Q4	$2.86B	Sell	93,468,786 -12,012,288	-11%	-$378M	0.87%	13
2015 Q3	$3.14B	Sell	105,481,074 -7,827,811	-7%	-$251M	0.96%	6
2015 Q2	$3.6B	Sell	113,308,885 -13,358,512	-11%	-$435M	0.99%	6
2015 Q1	$4.18B	Sell	126,667,397 -1,238,821	-1%	-$39.4M	1.09%	6
2014 Q4	$3.78B	Buy	127,906,218 +1,843,464	+1%	+$52.9M	0.99%	6
2014 Q3	$3.54B	Sell	126,062,754 -4,123,730	-3%	-$116M	0.96%	6
2014 Q2	$3.67B	Sell	130,186,484 -5,254,837	-4%	-$150M	0.99%	7
2014 Q1	$4.13B	Sell	135,441,321 -525,594	-0.4%	-$15.7M	1.12%	7
2013 Q4	$3.95B	Sell	135,966,915 -3,875,284	-3%	-$113M	1.1%	8
2013 Q3	$3.81B	Sell	139,842,199 -1,742,522	-1%	-$47.4M	1.13%	8
2013 Q2	$3.76B	Buy	+141,584,721	New	+$3.91B	1.19%	8

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of New York Mellon's PFE Position: Q2 2026 in Review

Bank of New York Mellon increased its Pfizer (PFE) stake by 7.4% in Q2 2026, buying an estimated $105M and bringing the position to 57,879,546 shares worth $1.39B. The position accounts for 0.23% of the portfolio, ranked #70.

Bank of New York Mellon first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.18B in Q1 2015. 1,947 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bank of New York Mellon held 57,879,546 shares of Pfizer worth $1.39B as of Q2 2026.
Bank of New York Mellon bought 3,999,646 Pfizer shares in Q2 2026, an estimated $105M.
Pfizer made up 0.23% of Bank of New York Mellon's portfolio in Q2 2026, its #70 holding.
Bank of New York Mellon first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's Pfizer position peaked at $4.18B in Q1 2015.
1,947 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.